1. Home
  2. HYFM vs BIAF Comparison

HYFM vs BIAF Comparison

Compare HYFM & BIAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hydrofarm Holdings Group Inc.

HYFM

Hydrofarm Holdings Group Inc.

HOLD

Current Price

$0.93

Market Cap

4.4M

Sector

Industrials

ML Signal

HOLD

Logo bioAffinity Technologies Inc.

BIAF

bioAffinity Technologies Inc.

HOLD

Current Price

$1.59

Market Cap

4.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HYFM
BIAF
Founded
1977
2014
Country
United States
United States
Employees
N/A
57
Industry
Industrial Machinery/Components
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4M
4.6M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
HYFM
BIAF
Price
$0.93
$1.59
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
17.9K
157.0K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$134,252,000.00
N/A
Revenue This Year
$57.44
$20.95
Revenue Next Year
$5.71
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.79
$0.23
52 Week High
$4.78
$13.50

Technical Indicators

Market Signals
Indicator
HYFM
BIAF
Relative Strength Index (RSI) 41.65 40.66
Support Level $0.86 $1.30
Resistance Level $1.06 $1.79
Average True Range (ATR) 0.06 0.19
MACD -0.00 0.02
Stochastic Oscillator 40.45 20.97

Price Performance

Historical Comparison
HYFM
BIAF

About HYFM Hydrofarm Holdings Group Inc.

Hydrofarm Holdings Group Inc is an independent manufacturer and distributor of branded hydroponics equipment and supplies for controlled environment agriculture (CEA), including grow lights, climate control solutions, grow media, nutrients, and other products. Hydroponics involves growing plants in soilless media, often using artificial lighting in controlled indoor or greenhouse environments. Its products are used to cultivate cannabis, flowers, fruits, vegetables, grains, and herbs, enabling control over key factors such as temperature, humidity, light, nutrients, and pH. Its product portfolio spans lighting, grow media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies. The United States generates maximum revenue.

About BIAF bioAffinity Technologies Inc.

bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.

Share on Social Networks: